This interaction causes the release of TNF-α, which induces the hepatic inflammatory responses and liver fibrosis associated with T2DM, and the progression from non-alcoholic fatty liver disease to nonalcoholic steatohepatitis (NASH) (24). The gene discussed is TNF; the disease is metabolic dysfunction-associated steatohepatitis.